[The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet].

Subjects

Subjects :

Biological Therapy
Humans
Internet
Italy
Risk Assessment
Rheumatic Diseases drug therapy
Tumor Necrosis Factor-alpha antagonists & inhibitors

Details

Language :

Italian

ISSN :

0048-7449

Volume :

60

Issue :

2

Database :

MEDLINE

Journal :

Reumatismo

Publication Type :

Editorial & Opinion

Accession number :

18651050

Full Text :

https://doi.org/10.4081/reumatismo.2008.77